PharmacyCodes



Oxybutinin en es it fr

Oxybutinin Brand names, Oxybutinin Analogs

Oxybutinin Brand Names Mixture

  • No information avaliable

Oxybutinin Chemical_Formula

C22H31NO3

Oxybutinin RX_link

http://www.rxlist.com/cgi/generic/ditropan.htm

Oxybutinin fda sheet

Oxybutinin FDA

Oxybutinin msds (material safety sheet)

Oxybutinin MSDS

Oxybutinin Synthesis Reference

Brit. pat. 940540 (1963 to Mead Johnson)

Oxybutinin Molecular Weight

357.486 g/mol

Oxybutinin Melting Point

129-130 oC

Oxybutinin H2O Solubility

No information avaliable

Oxybutinin State

Solid

Oxybutinin LogP

4.683

Oxybutinin Dosage Forms

Patch; Syrup; Tablet; Tablet (extended-release)

Oxybutinin Indication

For the treatment of overactive bladder.

Oxybutinin Pharmacology

Oxybutynin is an antispasmodic, anticholinergic agent indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin relaxes bladder smooth muscle. Oxybutynin exhibits only one-fifth of the anticholinergic activity of atropine on the rabbit detrusor muscle, but four to ten times the antispasmodic activity. Antimuscarinic activity resides predominantly in the R-isomer.

Oxybutinin Absorption

Rapidly absorbed from gastrointestinal tract.

Oxybutinin side effects and Toxicity

LD50=1220 mg/kg (Orally in rats, Goldenthal)

Oxybutinin Patient Information

PATIENT INFORMATION
Patient should be informed that oxybutynin may produce drowsiness or blurred vision. Alcohal may enhance the drowsiness caused by anticholinergic agents. Fever and heat stroke can occur while anticholinergics are administered in the presence of high environmental temparature. Medication should be taken with the aid of liquids at approximately the same time each day. Patients should not chew, divide, or crush tablets.

Oxybutinin Organisms Affected

Humans and other mammals